New Drug Development
Consumer Tailored Global Bio New Drug Joint R&D Support Center
Main Role
Infrastructure to identify global bio new drug candidates
Support for bio new drug candidate research with industry-academia-research center / advanced medical industry
Strengthen the efficiency of new drug development and the competitiveness of the pharmaceutical industry
Support for Prospective Customer Tailored R&D
-
Candidate Development Support Project
- Derivation of candidates that can enter non-clinical trials for licensing through joint research on the development of candidates with domestic industry-academia-research institutes with the initial results of creative new drug development.
-
Base technology development support project
- Securing the relevant technology and realizing service items through joint research with domestic industry-academia-research institutes and new drug centers with promising technologies that can speed up the development of candidates and reduce costs.
-
Prospective customer-tailored technology service
- Supporting analysis and evaluation services for projects being developed independently by domestic drug development agencies
Inquiry
- Management Support Team
- kbionddc@kbiohealth.kr
- +82-43-200-9211
Optimization
- Supporting target verification support, Modeling and property prediction.
- Effective substance screening
- Support for protein modeling and characteristics prediction
- Candidate optimization
Inquiry
- Division of Biopharmaceutical Optimization
- soyoung@kbiohealth.kr
- +82-43-200-9511
Medicinal efficacy evaluation
- Pharmacology and efficacy evaluation of candidates
- Evaluation of immunological activity of candidates
- Toxicity evaluation
- PK/PD evaluation
- Support for the development of cell and gene medicine
Inquiry
- Division of Biodrug Evaluation
- kha@kbiohealth.kr
- +82-43-200-9311
Process
- Mass sample production through transient expression
- Support for design-based quality enhancement (QbD) technology
- Production cell line development
- Optimal production medium development
- Establishing quality based culture/purification process
- Development of the formulation of new drug candidates
- Mass sample production
Inquiry
- Division of Bioprocess Development
- jhkim@kbiohealth.kr
- +82-43-200-9411
Convergence Technology
- Physicochemical characterization of candidates
- Precision characterization using a mass spectrometer
- Quantitative and high-dimensional structural analysis of candidates
- Discovery of omics-based biomarkers
Inquiry
- Division of Biodrug Analysis
- gre7@kbiohealth.kr
- +82-43-200-9571